Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

NCT00117689 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Dysfunction
Rejection, Transplant
Transplantation, Liver

Interventions

BIOLOGICAL: Thymoglobulin
DRUG: Corticosteroid
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil

Sponsor

Genzyme, a Sanofi Company